DVA News and Press, DaVita Inc. From 03/02/23

Summary Mixed Q4 results throughout the P&L and per-patient measures. Projects flat bottom-line growth in FY23, with further downsides in FCF. Valuations aren't supportive of a re-rating or valuation upside. Net-net, rate hold. Investor Summary DaVita Inc. ( ...

Summary DaVita is a stock that has been in Warren Buffett's portfolio for many years. Now the company is under short-term pressure from higher patient costs, labor issues, higher interest expenses, and lower patient volumes. While lower patient volumes may be temporary, the company ...

Summary The Healthcare sector has endured a very nasty stretch after posting impressive 2022 relative returns. DaVita reported better-than-expected earnings but that came after the bar was lowered. With a reasonable valuation, there are growth challenges this year while the chart re...

DaVita ( NYSE: DVA ) was a notable underperformer in the S&P 500 on Thursday as the dialysis services provider slightly missed Q4 revenue estimates and issued in-line guidance amid ongoing labor challenges. While the company's quarterly adj. diluted earnings per share at $1.11...

DaVita, Inc. (DVA) Q4 2022 Earnings Conference Call February 22, 2023, 17:00 ET Company Participants Javier Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Conference Call Participants Andrew Mok - UBS Philip Chickering - Deutsc...

Image source: The Motley Fool. DaVita (NYSE: DVA) Q4 2022 Earnings Call Feb 22, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita (DVA) Q4 2022 Earnings Call Transcript

DaVita HealthCare Partners press release ( NYSE: DVA ): Q4 Non-GAAP EPS of $0.59. Revenue of $2.92B. Operating income was $256 million and adjusted operating income was $317 million for the three months ended December 31, 2022. Operating cash flow was $344 million and free...

DaVita Inc. 4th Quarter 2022 Results PR Newswire DENVER , Feb. 22, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. "We continue to have excitement and conviction in ...

Summary S&P 500 blended EPS growth for Q4 increases for the second week in a row, now expected to come in at -4.7%. Peak earnings season rolls on this week with 1,524 global companies expected to report, as investors start to focus on Consumer Discretionary names. Potential surp...

DaVita HealthCare Partners ( NYSE: DVA ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, after market close. The consensus EPS Estimate is $0.98 (-51.5% Y/Y) and the consensus Revenue Estimate is $2.93B (-0.3% Y/Y). Over the last 2 years, DVA has be...